Discovery of 2-[4-{{2-(2S,5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]-4-methyl-1-piperidinyl]-4-pyridinecarboxylic acid (ABT-279):: A very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes

被引:39
|
作者
Madar, David J. [1 ]
Kopecka, Hana [1 ]
Pireh, Daisy [1 ]
Yong, Hong [1 ]
Pei, Zhonghua [1 ]
Li, Xiaofeng [1 ]
Wiedeman, Paul E. [1 ]
Djuric, Stevan W. [1 ]
Von Geldern, Thomas W. [1 ]
Fickes, Michael G. [1 ]
Bhagavatula, Lakshmi [1 ]
McDermott, Todd [1 ]
Wittenberger, Steven [1 ]
Richards, Steven J. [1 ]
Longenecker, Kenton L. [1 ]
Stewart, Kent D. [1 ]
机构
[1] Abbott Labs, Metab Dis Res, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm060777o
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dipeptidyl peptidase-IV (DPP-IV) inhibitors are poised to be the next major drug class for the treatment of type 2 diabetes. Structure-activity studies of substitutions at the C5 position of the 2-cyanopyrrolidide warhead led to the discovery of potent inhibitors of DPP-IV that lack activity against DPP8 and DPP9. Further modification led to an extremely potent (Ki(DPP-IV)) 1.0 nM) and selective (Ki(DPP8) > 30 mu M; Ki(DPP9) > 30 mu M) clinical candidate, ABT-279, that is orally available, efficacious, and remarkably safe in preclinical safety studies.
引用
收藏
页码:6416 / 6420
页数:5
相关论文
共 50 条
  • [21] A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid
    Setoguchi, Masaki
    Iimura, Shin
    Sugimoto, Yuuichi
    Yoneda, Yoshiyuki
    Chiba, Jun
    Watanabe, Toshiyuki
    Muro, Fumihito
    Iigo, Yutaka
    Takayama, Gensuke
    Yokoyama, Mika
    Taira, Tomoe
    Aonuma, Misato
    Takashi, Tohru
    Nakayama, Atsushi
    Machinaga, Nobuo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (01) : 42 - 61
  • [22] Discovery of ((S)-5-(Methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective IKur Inhibitor
    Finlay, Heather J.
    Lloyd, John
    Vaccaro, Wayne
    Kover, Alexander
    Yan, Lin
    Bhave, Gauri
    Prol, Joseph
    Tram Huynh
    Bhandaru, Rao
    Caringal, Yolanda
    DiMarco, John
    Gan, Jinping
    Harper, Tim
    Huang, Christine
    Conder, Mary Lee
    Sun, Huabin
    Levesque, Paul
    Blanar, Michael
    Atwal, Karnail
    Wexler, Ruth
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (07) : 3036 - 3048
  • [23] Discovery of N-(4-{[5-Fluoro-7-(2-methoxyethoxy)quinazolin-4-yl]amino}phenyl)-2-[4-(propan-2-yl)-1H-1,2,3-triazol-1-yl]acetamide (AZD3229), a Potent Pan-KIT Mutant Inhibitor for the Treatment of Gastrointestinal Stromal Tumors
    Kettle, Jason G.
    Anjum, Rana
    Barry, Evan
    Bhavsar, Deepa
    Brown, Crystal
    Boyd, Scott
    Campbell, Andrew
    Goldberg, Kristin
    Grondine, Michael
    Guichard, Sylvie
    Hardy, Christopher J.
    Hunt, Tom
    Jones, Rhys D. O.
    Li, Xiuwei
    Moleva, Olga
    Ogg, Derek
    Overman, Ross C.
    Packer, Martin J.
    Pearson, Stuart
    Schimpl, Marianne
    Shao, Wenlin
    Smith, Aaron
    Smith, James M.
    Stead, Darren
    Stokes, Steve
    Tucker, Michael
    Ye, Yang
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) : 8797 - 8810
  • [24] Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma
    af Rosenschold, Magnus Munck
    Johannesson, Petra
    Nikitidis, Antonios
    Tyrchan, Christian
    Chang, Hui-Fang
    Ronn, Robert
    Chapman, Dave
    Ullah, Victoria
    Nikitidis, Grigorios
    Glader, Pernilla
    Kack, Helena
    Bonn, Britta
    Wagberg, Fredrik
    Bjorkstrand, Eva
    Andersson, Ulf
    Swedin, Linda
    Rohman, Mattias
    Andreasson, Theresa
    Bergstrom, Eva Lamm
    Jiang, Fanyi
    Zhou, Xiao-Hong
    Lundqvist, Anders J.
    Malmberg, Anna
    Ek, Margareta
    Gordon, Euan
    Pettersen, Anna
    Ripa, Lena
    Davis, Andrew M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (17) : 7769 - 7787
  • [25] A Potent, Selective, and Orally Bioavailable HCV NS5A Inhibitor for Treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazol-2-yl)pyrrolidine-2-carboxamide
    Kang, Iou-Jiun
    Hsu, Sheng-Ju
    Yang, Hui-Yun
    Yeh, Teng-Kuan
    Lee, Chung-Chi
    Lee, Yen-Chun
    Tian, Ya-Wen
    Song, Jen-Shin
    Hsu, Tsu-An
    Chao, Yu-Sheng
    Yueh, Andrew
    Chern, Jyh-Haur
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (01) : 228 - 247
  • [26] Discovery of methyl 3-((2-((1-(dimethylglycyl)-5-methoxyindolin-6-yl)amino)-5-(trifluoro-methyl) pyrimidin-4-yl)amino)thiophene-2-carboxylate as a potent and selective polo-like kinase 1 (PLK1) inhibitor for combating hepatocellular carcinoma
    Deng, Zhou
    Chen, Guyue
    Liu, Shuang
    Li, Yunzhan
    Zhong, Jiaji
    Zhang, Baoding
    Li, Li
    Huang, Huiying
    Wang, Zheng
    Xu, Qingyan
    Deng, Xianming
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 206
  • [27] Exploring the role of bromine at C(10) of (+)-4-[2-[4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide (Sch-66336):: The discovery of indolocycloheptapyridine inhibitors of farnesyl protein transferase
    Taveras, AG
    Aki, C
    Chao, JP
    Doll, RJ
    Lalwani, T
    Girijavallabhan, V
    Strickland, CL
    Windsor, WT
    Weber, P
    Hollinger, F
    Snow, M
    Patton, R
    Kirschmeier, P
    James, L
    Liu, M
    Nomeir, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) : 3854 - 3864
  • [28] Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
    Blake, James F.
    Burkard, Michael
    Chan, Jocelyn
    Chen, Huifen
    Chou, Kang-Jye
    Diaz, Dolores
    Dudley, Danette A.
    Gaudino, John J.
    Gould, Stephen E.
    Grina, Jonas
    Hunsaker, Thomas
    Liu, Lichuan
    Martinson, Matthew
    Moreno, David
    Mueller, Lars
    Orr, Christine
    Pacheco, Patricia
    Qin, Ann
    Rasor, Kevin
    Ren, Li
    Robarse, Kirk
    Shahidi-Latham, Sheerin
    Stults, Jeffrey
    Sullivan, Francis
    Wang, Weiru
    Yin, Jianping
    Zhou, Aihe
    Belvin, Marcia
    Merchant, Mark
    Moffat, John
    Schwarz, Jacob B.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (12) : 5650 - 5660
  • [29] Discovery of (R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4-b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies
    Wang, Hui-Ling
    Andrews, Kristin L.
    Booker, Shon K.
    Canon, Jude
    Cee, Victor J.
    Chavez, Frank, Jr.
    Chen, Yuping
    Eastwood, Heather
    Guerrero, Nadia
    Herberich, Brad
    Hickman, Dean
    Lanman, Brian A.
    Laszlo, Jimmy, III
    Lee, Matthew R.
    Lipford, J. Russell
    Mattson, Bethany
    Mohr, Christopher
    Yen Nguyen
    Norman, Mark H.
    Pettus, Liping H.
    Powers, David
    Reed, Anthony B.
    Rex, Karen
    Sastri, Christine
    Tamayo, Nuria
    Wang, Paul
    Winston, Jeffrey T.
    Wu, Bin
    Wu, Qiong
    Wu, Tian
    Wurz, Ryan P.
    Xu, Yang
    Zhou, Yihong
    Tasker, Andrew S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (03) : 1523 - 1540
  • [30] The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent
    Sampson, Peter B.
    Liu, Yong
    Forrest, Bryan
    Cumming, Graham
    Li, Sze-Wan
    Patel, Narendra Kumar
    Edwards, Louise
    Laufer, Radoslaw
    Feher, Miklos
    Ban, Fuqiang
    Awrey, Donald E.
    Mao, Guodong
    Plotnikova, Olga
    Hodgson, Richard
    Beletskaya, Irina
    Mason, Jacqueline M.
    Luo, Xunyi
    Nadeem, Vincent
    Wei, Xin
    Kiarash, Reza
    Madeira, Brian
    Huang, Ping
    Mak, Tak W.
    Pan, Guohua
    Pauls, Henry W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) : 147 - 169